2,100 Shares in Avantor, Inc. (NYSE:AVTR) Acquired by Wealthquest Corp

Wealthquest Corp purchased a new stake in Avantor, Inc. (NYSE:AVTR) during the 1st quarter, Holdings Channel.com reports. The institutional investor purchased 2,100 shares of the company’s stock, valued at approximately $34,000.

A number of other institutional investors and hedge funds also recently modified their holdings of AVTR. GAMMA Investing LLC raised its holdings in shares of Avantor by 121.6% during the first quarter. GAMMA Investing LLC now owns 3,747 shares of the company’s stock valued at $61,000 after acquiring an additional 2,056 shares during the period. Fifth Third Bancorp raised its stake in Avantor by 52.0% during the 1st quarter. Fifth Third Bancorp now owns 3,972 shares of the company’s stock valued at $64,000 after purchasing an additional 1,359 shares during the period. Signaturefd LLC raised its stake in Avantor by 19.8% during the 1st quarter. Signaturefd LLC now owns 5,470 shares of the company’s stock valued at $89,000 after purchasing an additional 904 shares during the period. Archer Investment Corp purchased a new stake in shares of Avantor in the first quarter valued at $112,000. Finally, UMB Bank n.a. boosted its position in shares of Avantor by 137.9% in the first quarter. UMB Bank n.a. now owns 7,093 shares of the company’s stock worth $115,000 after buying an additional 4,112 shares during the period. Institutional investors and hedge funds own 95.08% of the company’s stock.

Avantor Price Performance

NYSE AVTR opened at $11.37 on Friday. The company has a quick ratio of 0.75, a current ratio of 1.12 and a debt-to-equity ratio of 0.54. The stock has a market capitalization of $7.75 billion, a PE ratio of 10.93, a price-to-earnings-growth ratio of 1.43 and a beta of 0.96. Avantor, Inc. has a 12-month low of $10.82 and a 12-month high of $27.83. The company has a 50 day moving average price of $13.37 and a two-hundred day moving average price of $15.49.

Avantor (NYSE:AVTR) last released its quarterly earnings data on Friday, August 1st. The company reported $0.24 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.25 by ($0.01). The business had revenue of $1.68 billion during the quarter, compared to analyst estimates of $1.67 billion. Avantor had a net margin of 10.70% and a return on equity of 11.93%. The firm’s revenue for the quarter was down 1.1% on a year-over-year basis. During the same period in the previous year, the firm posted $0.25 EPS. As a group, equities analysts predict that Avantor, Inc. will post 1.06 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, Director Gregory L. Summe purchased 30,000 shares of Avantor stock in a transaction on Friday, May 23rd. The stock was bought at an average price of $12.50 per share, with a total value of $375,000.00. Following the completion of the transaction, the director directly owned 100,000 shares of the company’s stock, valued at approximately $1,250,000. This represents a 42.86% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders have acquired 75,000 shares of company stock worth $928,000 over the last 90 days. Corporate insiders own 1.20% of the company’s stock.

Analysts Set New Price Targets

Several research firms recently weighed in on AVTR. Robert W. Baird upped their price target on Avantor from $17.00 to $18.00 and gave the company an “outperform” rating in a research report on Monday, July 28th. Cowen downgraded Avantor from a “buy” rating to a “hold” rating in a report on Monday, April 28th. Wells Fargo & Company decreased their price target on shares of Avantor from $25.00 to $22.00 and set an “overweight” rating for the company in a report on Thursday, April 17th. Barclays dropped their price objective on shares of Avantor from $18.00 to $15.00 and set an “overweight” rating on the stock in a research note on Monday, April 28th. Finally, Jefferies Financial Group reiterated a “hold” rating on shares of Avantor in a research report on Friday. Eight investment analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $18.23.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.